Nitrosamine Impurities Affecting Drug-Drug Interaction Studies – Learn More

About

News & Events

News

Celerion Expands UK Phase 1 Clinical Research Operations With New Agreement to Relocate to Queen’s University Belfast’s iREACH Health – Clinical Research Innovation Center 

02.19.25

Celerion Pledges Commitment to the Science-Based Targets Initiative (SBTi) Net-Zero Standard

12.04.24

Celerion’s US Pharmacies Expand On-Site Services, Ensure cGMP FDA Compliance for Phase 1 Investigational Drugs

07.17.24

All News

Events

AAPS NBC

05.04.2025 - 05.07.2025

OCT East Coast (2025)

05.20.2025 - 05.21.2025

ASCPT (2025)

05.28.2025 - 05.31.2025

All Events

Blog Posts

FDA Endorses Human-Relevant Nonclinical Models: A Welcome Shift for Monoclonal Antibody Development

04.17.25

Ruling the Future: How the ACLA’s LDT Court Victory and Europe’s IVDR Are Shaping Bioanalytical Laboratories

04.03.25

Reframing the Definition of Obesity

02.24.25

All Blog Posts